Advertisement

Topics

AmpliPhi Biosciences Establishes Scientific Advisory Board and Appoints Dr. Timothy Lu of MIT and Broad Institute as SAB Chairman

06:50 EST 23 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a global leader in the development of bacteriophage-based therapies to treat drug-resistant bacterial infections, announces the formation of its Scientific Advisory Board (SAB) ...

Other Sources for this Article

Company Contact
Matthew Dansey
AmpliPhi Biosciences
858-800-4869
md@ampliphibio.com
or
Investor Relations
Jody Cain
LHA
310-691-7100
jcain@lhai.com
or
Media Relations (U.S.)
Danielle Lewis/Glenn Silver
Lazar Partners
212-867-1762
ampliphi@lazarpartners.com
or
Media Relations (Europe and ROW)
Gemma Howe/Sue Charles
Instinctif Partners
+44 (0)20 7866 7860
ampliphi@instinctif.com

NEXT ARTICLE

More From BioPortfolio on "AmpliPhi Biosciences Establishes Scientific Advisory Board and Appoints Dr. Timothy Lu of MIT and Broad Institute as SAB Chairman"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...